TABLE OF CONTENTS

4 OVERVIEW

4 Drug Overview

5 Product Profiles

5 Anoro Ellipta : Chronic obstructive pulmonary disease (COPD)

LIST OF FIGURES
12 Figure 1: Anoro for COPD - SWOT analysis

13 Figure 2: Datamonitor Healthcare's drug assessment summary of Anoro for COPD

14 Figure 3: Datamonitor Healthcare's drug assessment summary of Anoro for COPD

17 Figure 4: Anoro sales for COPD across the US, Japan, and five major EU markets, by country, 2017-26

LIST OF TABLES
6 Table 1: Anoro drug profile

7 Table 2: Anoro Phase III data in COPD
18 Table 3: Anoro sales for COPD across the US, Japan, and five major EU markets, by country ($m), 2017-26